Secondary analysis of two trials (CLOuD, USTEKID; 169 youths aged 10–18 with new type 1 diabetes): quality-of-life and hypoglycaemia-fear scores changed little over 48 months, linked modestly to HbA1c and time in range but not significantly to C-peptide.
Secondary analysisn = 169
Taylor et al. Relationship between participant-reported outcomes, residual beta cell function and metabolic parameters in youth with newly diagnosed type 1 diabetes